Disclosure 0001159036-26-000108-11

SEC FORM 4

$368,200.00

HALOZYME THERAPEUTICS, INC. (HALO)

Acquisition (code M) of 20,000 shares at $18.41 per share.

Reporting Person Torley Helen · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001159036-26-000108 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "HALOZYME THERAPEUTICS, INC. (HALO)." Disclosed 2026-08-19. https://desqlong.com/cards/0001159036-26-000108-11 (retrieved 2026-09-26).